CLLS Stock Analysis: Buy, Sell, or Hold?
CLLS - Cellectis S.A. American Depositary Shares
$2.89
0.10 (3.58%)
▲
5d:
-6.17%
30d:
-21.25%
90d:
-14.24%
HOLD
LOW Confidence
Analysis Updated: Jun 25, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When CLLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLLS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CLLS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CLLS is currently trading at $2.89, which is considered oversold relative to its 30-day fair value range of $2.94 to $3.55.
Technical Outlook: Technically, CLLS is in a downtrend. Immediate support is located at $2.70, while resistance sits at $3.25. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: CLLS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.60 (+163.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLLS is in a downtrend. Immediate support is located at $2.70, while resistance sits at $3.25. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: CLLS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.60 (+163.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.94 -
$3.55
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 163.0% below Wall St target ($7.60)
- CAUTION: Recommendation downgraded due to -6.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$2.94 -
$3.55
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.70
Resistance Level
$3.25
Current Trend
Downtrend
Technical data as of
Jun 25, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.26
Wall Street Target
$7.60
(+163.0%)
Revenue Growth (YoY)
-37.3%
Profit Margin
-89.5%
Share & Embed Analysis
Last updated: June 26, 2026 4:41 AM ET
Data refreshes hourly during market hours. Next update: 5:41 AM
Data refreshes hourly during market hours. Next update: 5:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLLS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 56 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 58 HOLD |
|
MNMD
Mind Medicine Inc |
STRONG BUY
11 analysts |
$29 | 62 BUY |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 60 HOLD |
